(Q44454339)

English

N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

Darell D. Bigner

3

object named as

Darell D Bigner

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Ganesan Vaidyanathan

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Donna J Affleck

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Michael R Zalutsky

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Nuclear Medicine and Biology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

351-359

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Receptor blockade with monoclonal antibodies as anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioimmunotherapy for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis, purification, and in vitro stability of 211At- and 125I-labeled amidobisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: comparison with its murine parent

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB).

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900005-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0969-8051(03)00005-2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44454339&oldid=2024696070"